HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Contribution of imidazoline receptors and alpha2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine.

AbstractOBJECTIVES:
To determine whether the hypotensive and sympathetic baroreflex inhibition by rilmenidine administered systemically are mediated via imidazoline receptors in the rostral ventrolateral medulla (RVLM).
METHODS:
Initial dose-response curves to rilmenidine were determined in urethane anaesthetized rabbits. Effects of a single intravenous dose of rilmenidine (445 microg/kg) on the renal sympathetic nerve activity (RSNA) baroreflex were examined before and after microinjection into the RVLM of the mixed imidazoline/alpha2-adrenoceptor antagonist idazoxan and the alpha2-adrenoceptor antagonist 2-methoxyidazoxan (2-MI).
RESULTS:
Intravenous administration of rilmenidine lowered mean arterial pressure and RSNA, inhibited the RSNA baroreflex range by 33% and shifted the baroreflex curve to the left. Idazoxan injected into the RVLM reversed the hypotension and completely restored the baroreflex curve at doses that did not affect the hypotension produced by the selective alpha2-adrenoceptor agonist alpha-methylnoradrenaline. The alpha2-adrenoceptor antagonist, 2-MI also reversed the rilmenidine sympatho-inhibition suggesting that alpha2-adrenoceptors are activated as well.
CONCLUSIONS:
The results of the present study show that the hypotensive and sympatho-inhibitory actions of systemic rilmenidine are primarily mediated via imidazoline receptors in the RVLM. However, alpha2-adrenoceptors are also involved, probably as a direct result of the imidazoline receptor action.
AuthorsCandy K S Chan, Sandra L Burke, Geoffrey A Head
JournalJournal of hypertension (J Hypertens) Vol. 25 Issue 1 Pg. 147-55 (Jan 2007) ISSN: 0263-6352 [Print] England
PMID17143186 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adrenergic alpha-2 Receptor Agonists
  • Adrenergic alpha-Agonists
  • Adrenergic alpha-Antagonists
  • Antihypertensive Agents
  • Imidazoline Receptors
  • Oxazoles
  • Receptors, Adrenergic, alpha-2
  • Receptors, Drug
  • imidazoline I1 receptors
  • 2-methoxyidazoxan
  • Rilmenidine
  • Idazoxan
Topics
  • Adrenergic alpha-2 Receptor Agonists
  • Adrenergic alpha-Agonists (administration & dosage, pharmacology)
  • Adrenergic alpha-Antagonists (pharmacology)
  • Animals
  • Antihypertensive Agents (administration & dosage, pharmacology)
  • Baroreflex (drug effects)
  • Blood Pressure (drug effects)
  • Dose-Response Relationship, Drug
  • Idazoxan (analogs & derivatives, pharmacology)
  • Imidazoline Receptors
  • Injections, Intravenous
  • Kidney (innervation)
  • Medulla Oblongata (drug effects, metabolism)
  • Neural Inhibition (drug effects)
  • Oxazoles (administration & dosage, pharmacology)
  • Rabbits
  • Receptors, Adrenergic, alpha-2 (metabolism)
  • Receptors, Drug (agonists, metabolism)
  • Rilmenidine
  • Sympathetic Nervous System (drug effects, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: